This paper highlights the status of the Indian biopharmaceutical industry and also makes a comparison with the global scenario. It also discusses the current situation regarding patenting biopharmaceuticals in India. [GIDR WP no. 168].

This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs,and the future returns to research and development (R&D). While there still remains an abundance of...

Poor quality essential medicines, both substandard and counterfeit, are serious but neglected public health problems. Anti-infective medicines are particularly afflicted. Unfortunately, attempts to improve medicine quality have been hampered by confusion and controversy over definitions. For...

This paper investigates the effects of plants' dynamics on productivity growth in the Indian pharmaceutical industry across five regions: north, north-west, west, south and the rest of India, during the period from 2000-01 to 2005-06, using the unit-level panel database drawn from the Annual...

The relationship between health professionals and the pharmaceutical industry has become a source of controversy. Physicians’ attitudes towards the industry can form early in their careers, but little is known about this key stage of development. A search in MEDLINE, EMBASE, Web of...

Budget expectations from various sectors are given. URL:[ http://www.myiris.com/newsCentre/storyShow.php?fileR=20110217120638043&secID=fromnewsroom&secTitle=From the News Room&dir=2011/02/17].

The political economy of the pharmaceutical industry defines truth significantly, if not substantially and wholly, in medicine as much as does dominant medical practice. This mediated wisdom of medicine is purveyed across populations through public health policies affecting millions as is seen...

Three important aspects of the Canadian pharmaceutical industry-viz. compulsory licence, price control on patented drugs and the R&D scenario. Unlike other developed countries, which have adopted the route of providing higher Intellectual Property Rights (IPR) protection to promote the growth of...

This paper uses aggregate and firm level data to examine the characteristics of the Chinese pharmaceutical industry in general and its geographical agglomeration in particular. It addresses the following research questions: 1) Are there geographical agglomerations in China’s...

There are many reports of ghost writings and ghost management of medical journal articles. Such articles are “ghostly†because signs of their actual production are largely invisible—academic authors whose names appear at the top of ghost-managed articles give corporate research...